|
Post by uvula on Jul 25, 2020 18:37:57 GMT -5
|
|
|
Post by shawnonafrezza on Jul 25, 2020 18:44:08 GMT -5
Sec. 2. Policy. It is the policy of the United States to enable Americans without access to affordable insulin and injectable epinephrine through commercial insurance or Federal programs, such as Medicare and Medicaid, to purchase these pharmaceuticals from an FQHC at a price that aligns with the cost at which the FQHC acquired the medication.
This demographic never would have been able to afford Afrezza anyways.
|
|
|
Post by nylefty on Jul 25, 2020 19:55:53 GMT -5
"... the moves are largely symbolic because the orders are unlikely to take effect anytime soon, if they do so at all, because the power to implement drug pricing policy through executive order is limited. Voters will not see an impact before the November elections, and the drug industry is sure to challenge them in court."
|
|
|
Post by falconquest on Jul 26, 2020 4:13:03 GMT -5
"... the moves are largely symbolic because the orders are unlikely to take effect anytime soon, if they do so at all, because the power to implement drug pricing policy through executive order is limited. Voters will not see an impact before the November elections, and the drug industry is sure to challenge them in court." Not trying to get political one way or the other but quite often politicians will vote for something, pass something or in this case, sign an executive order simply to be able to state, I made sweeping changes to "X" when in reality its basically meaningless as nylefty pointed out.
|
|
|
Post by slugworth008 on Jul 27, 2020 11:27:32 GMT -5
THe drug execs are to meet with Trump and come up with a price reduction plan by August 24th - Or he'll move forward with executive orders. It's the art of the deal in action _JMHO
|
|
|
Post by itellthefuture777 on Jul 27, 2020 12:01:46 GMT -5
So what the order says is that under current law the government pays a penny a unit and allows for an administration fee but that the patient ends up paying more than the government. The manufacturers already provide at the lower prices for these patients it was the middle men that hiked the prices!! Thus~ no effect on Mannkind except positive imo~
|
|
|
Post by itellthefuture777 on Jul 27, 2020 12:07:56 GMT -5
www.insulinsavings.comAnd remember..you would use more units of Afrezza then all other insulins..as it doesn't stack..like all the rest do..hmm
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jul 27, 2020 17:29:08 GMT -5
"... the moves are largely symbolic because the orders are unlikely to take effect anytime soon, if they do so at all, because the power to implement drug pricing policy through executive order is limited. Voters will not see an impact before the November elections, and the drug industry is sure to challenge them in court." Not trying to get political one way or the other but quite often politicians will vote for something, pass something or in this case, sign an executive order simply to be able to state, I made sweeping changes to "X" when in reality its basically meaningless as nylefty pointed out. So what you're referring to is SMOKE and MIRRORS?
|
|
|
Post by Chris-C on Jul 28, 2020 17:16:22 GMT -5
Not trying to get political one way or the other but quite often politicians will vote for something, pass something or in this case, sign an executive order simply to be able to state, I made sweeping changes to "X" when in reality its basically meaningless as nylefty pointed out. So what you're referring to is SMOKE and MIRRORS? Except that there IS a fire (actually many); but I doubt that very many people in the hotspots are worried much about insulin prices as their #1 concern these days. Perhaps a more effective approach (in all respects) would be to implore Congress to enable the CMS to negotiate drug prices with companies under part D of Medicare. That would be a terrific start.
|
|
|
Post by shawnonafrezza on Jul 28, 2020 19:52:09 GMT -5
I'd argue the most effective approach is to look at countries that don't have this problem. It's already solved.
|
|
|
Post by rfogel on Jul 28, 2020 20:58:37 GMT -5
I vaguely recall reading here that one of the manufacturers -- Lilly? -- had got prices down to $35 a month. That seems pretty cheap to me.
|
|
|
Post by shawnonafrezza on Jul 28, 2020 21:23:31 GMT -5
A friend in Germany pays the equivilant of like $10 every 3 months on a public plan fir his insulin. Even the $35 isn't "got prices down", it's "let profits go to". They always could and chose not to and people died.
A vial costs $3USD to make.
|
|
|
Post by seanismorris on Jul 28, 2020 22:18:20 GMT -5
You don’t understands how Trump works. An executive order is meaningless when it comes from him. It’s request to negotiate... and PR.
If it was an act of Congress that’s a whole nother ballgame. But, many of them had pharma money getting them elected... so good luck with bringing down prices.
I wouldn’t worry about.
|
|
|
Post by agedhippie on Jul 29, 2020 8:44:57 GMT -5
A friend in Germany pays the equivilant of like $10 every 3 months on a public plan fir his insulin. Even the $35 isn't "got prices down", it's "let profits go to". They always could and chose not to and people died. A vial costs $3USD to make. Insulin is free in the UK, the NHS absorbs the cost. The idea is that if you can keep people out of hospital it is good for the budget, which is true if you are on the hook for a whole life cost and not just the next four or so years. The NHS pay £14.08 (about $18 at today's rates) for a 10mL vial of Fiasp insulin.
|
|
|
Post by Chris-C on Jul 29, 2020 10:04:25 GMT -5
Arguably, these winds of change tend to support a strategy to focus on development and licensing of the technophere delivery platform as the main business of MNKD.
|
|